Cargando…
Experimental Pharmaceuticals for Steroid-Refractory Acute Graft-versus-Host Disease
Acute GVHD (aGVHD) is a significant complication after allogeneic hematopoietic cell transplantation (HCT), occurring in up to 70% of HCT recipients. Steroid-refractory aGVHD represents a subset of patients failing initial therapy and is particularly morbid, with only 30% of patients surviving long...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7705269/ https://www.ncbi.nlm.nih.gov/pubmed/33273867 http://dx.doi.org/10.2147/JEP.S259290 |